Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10900367 | Cancer Letters | 2005 | 7 Pages |
Abstract
The HIC1 gene is a transcriptional regulator commonly methylated in a variety of human cancer. Thirty-three invasive ductal carcinomas of the breast and 21 matched normal breast tissues were analysed for HIC1 promoter methylation, and allelic loss of a 700Â kb region spanning the gene locus. At least one genetic or epigenetic abnormality was found in 27 of the carcinomas tested (82%). Promoter methylation was demonstrated in 21 carcinomas (64%), and nine normal tissues (43%), whereas 18 malignant tumors (54%) showed allelic loss. Concomitant loss of heterozigosity and promoter hypermethylation in the region spanning HIC1 was detected in eight carcinomas (24%) suggesting that in this subset of tumors both copies of the gene are functionally lost. These observations support a role for the HIC1 gene in the pathogenesis of breast ductal carcinomas.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Paola Parrella, Marina Scintu, Maria Prencipe, Maria Luana Poeta, Antonietta Pia Gallo, Carla Rabitti, Monica Rinaldi, Stefania Tommasi, Angelo Paradiso, Francesco Schittulli, Vanna Maria Valori, Salvatore Toma, Vittorio Altomare, Vito Michele Fazio,